Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 21, 2020; 26(27): 3851-3864
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3851
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3851
Figure 1 Risk factors for post-liver transplant diabetes mellitus[3].
PTDM: Post-transplant diabetes mellitus; CNI: Calcineurin inhibitor; mTORi: Mammalian target of rapamycin; HCV: Hepatitis C virus; CMV: Cytomegalovirus.
- Citation: Shen T, Zhuang L, Sun XD, Qi XS, Wang ZH, Li RD, Chang WX, Yang JY, Yang Y, Zheng SS, Xu X. Expert consensus on management of metabolic disease in Chinese liver transplant recipients. World J Gastroenterol 2020; 26(27): 3851-3864
- URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3851